Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Horowitz

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cancer Research|March 1, 1987
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapyM P Goren, R K Wright, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapyL H Wexler, L Weaver-McClure, S M Steinberg, et al.
Gastroenterology|May 1, 1983
Increased blood-brain transfer in a rabbit model of acute liver failureM E Horowitz, D F Schafer, P Molnar, et al.
Cancer|February 1, 1988
Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatmentM E Horowitz, R K Mulhern, L E Kun, et al.
Ultrastructural Pathology|September 1, 1995
Malignant melanoma of soft parts involving the head and neck region: review of literature and case reportM J Hicks, V A Saldivar, M M Chintagumpala, et al.
Neuro-Oncology|September 14, 2001
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experienceP K Duffner, M E Horowitz, J P Krischer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.
Pediatric Neurosurgery|September 10, 1998
Prognostic factors in infants and very young children with intracranial ependymomasP K Duffner, J P Krischer, R A Sanford, et al.
Medical and Pediatric Oncology|July 1, 1995
Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology GroupP K Duffner, M E Cohen, R A Sanford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesnaC B Pratt, A A Green, M E Horowitz, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|March 1, 1987
Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapyM P Goren, R K Wright, C B Pratt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapyL H Wexler, L Weaver-McClure, S M Steinberg, et al.
Gastroenterology|May 1, 1983
Increased blood-brain transfer in a rabbit model of acute liver failureM E Horowitz, D F Schafer, P Molnar, et al.
Cancer|February 1, 1988
Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatmentM E Horowitz, R K Mulhern, L E Kun, et al.
Ultrastructural Pathology|September 1, 1995
Malignant melanoma of soft parts involving the head and neck region: review of literature and case reportM J Hicks, V A Saldivar, M M Chintagumpala, et al.
Neuro-Oncology|September 14, 2001
The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experienceP K Duffner, M E Horowitz, J P Krischer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicityM P Goren, A A Forastiere, R K Wright, et al.
Pediatric Neurosurgery|September 10, 1998
Prognostic factors in infants and very young children with intracranial ependymomasP K Duffner, J P Krischer, R A Sanford, et al.
Medical and Pediatric Oncology|July 1, 1995
Lack of efficacy of postoperative chemotherapy and delayed radiation in very young children with pineoblastoma. Pediatric Oncology GroupP K Duffner, M E Cohen, R A Sanford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesnaC B Pratt, A A Green, M E Horowitz, et al.
Pageof 8